AstraZeneca eyed a merger with Gilead Sciences
AstraZeneca informally contacted with the Gilead Sciences last month to display its interest in this tie-up. If the transaction were to take place, it would
AstraZeneca informally contacted with the Gilead Sciences last month to display its interest in this tie-up. If the transaction were to take place, it would
Takeda Pharmaceutical Company Limited displayed its financial year 2019 results which has accelerated its transformation.